Showing 21-23 of 23 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema | Jaeb Center for Health Research | Adam Glassman | Improving Lives | 01-September-2022 to 01-January-2026 | $273,424.00 |
| Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes | iTolerance, Inc. | Camillo Ricordi | Cures | 01-June-2022 to 15-November-2026 | $850,000.00 |
| Repurposing Cardiorenal Drugs for T1D: Building Evidence from Existing Trials (ReCaRD T1D) | AdventHealth | Richard Pratley | Improving Lives | 01-September-2023 to 20-May-2026 | $110,840.00 |